Growth Metrics

Incyte (INCY) Share-based Compensation (2010 - 2026)

Incyte posted quarterly Share-based Compensation of $64.1 million for Q1 2026, up 5.16% year-on-year from $61.0 million in Q1 2025, and up 3.17% on a QoQ basis from $62.2 million in Q4 2025.

Incyte (INCY) has 17 years of Share-based Compensation data on file, last reported at $64.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 5.16% year-over-year to $64.1 million; the trailing twelve-month figure through Mar 2026 stood at $252.5 million (down 5.53% YoY), and the FY2025 full-year result was $249.3 million, down 6.28% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $64.1 million, up from $62.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $77.9 million in Q3 2024 and bottomed at $43.8 million in Q1 2022.
  • The 5-year median for Share-based Compensation is $59.8 million (2024), against an average of $57.9 million.
  • The widest annual swing landed in 2024, when Share-based Compensation surged 62.34%; it then slipped 20.95% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $52.7 million in 2022, then gained by 13.88% to $60.0 million in 2023, then advanced by 19.55% to $71.7 million in 2024, then retreated by 13.33% to $62.2 million in 2025, then advanced by 3.17% to $64.1 million in 2026.
  • The last three Share-based Compensation figures came in at $64.1 million (Q1 2026), $62.2 million (Q4 2025), and $61.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 892,057.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 305,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 166.40 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 257.40 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 70.15 Mn
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn 64.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 64.13 Mn
Mar 31, 2026 64.13 Mn
Dec 31, 2025 62.16 Mn
Dec 31, 2025 62.16 Mn
Sep 30, 2025 61.60 Mn
Sep 30, 2025 61.60 Mn
Jun 30, 2025 64.61 Mn
Jun 30, 2025 64.61 Mn
Mar 31, 2025 60.98 Mn
Mar 31, 2025 60.98 Mn
Dec 31, 2024 71.72 Mn
Dec 31, 2024 71.72 Mn
Sep 30, 2024 77.92 Mn
Sep 30, 2024 77.92 Mn
Jun 30, 2024 56.64 Mn
Jun 30, 2024 56.64 Mn
Mar 31, 2024 59.78 Mn
Mar 31, 2024 59.78 Mn
Dec 31, 2023 59.99 Mn
Dec 31, 2023 59.99 Mn
Sep 30, 2023 48.00 Mn
Sep 30, 2023 48.00 Mn
Jun 30, 2023 54.52 Mn
Jun 30, 2023 54.52 Mn
Mar 31, 2023 53.38 Mn
Mar 31, 2023 53.38 Mn
Dec 31, 2022 52.68 Mn
Dec 31, 2022 52.68 Mn
Sep 30, 2022 45.40 Mn
Sep 30, 2022 45.40 Mn
Jun 30, 2022 46.50 Mn
Jun 30, 2022 46.50 Mn
Mar 31, 2022 43.84 Mn
Mar 31, 2022 43.84 Mn
Dec 31, 2021 48.22 Mn
Dec 31, 2021 48.22 Mn
Sep 30, 2021 42.70 Mn
Sep 30, 2021 42.70 Mn
Jun 30, 2021 44.80 Mn
Jun 30, 2021 44.80 Mn
Mar 31, 2021 47.36 Mn
Mar 31, 2021 47.36 Mn
Dec 31, 2020 45.26 Mn
Dec 31, 2020 45.26 Mn
Sep 30, 2020 43.80 Mn
Sep 30, 2020 43.80 Mn
Jun 30, 2020 46.30 Mn
Jun 30, 2020 46.30 Mn
Mar 31, 2020 42.51 Mn
Mar 31, 2020 42.51 Mn
Dec 31, 2019 42.02 Mn
Dec 31, 2019 42.02 Mn
Sep 30, 2019 43.40 Mn
Sep 30, 2019 43.40 Mn
Jun 30, 2019 40.60 Mn
Jun 30, 2019 40.60 Mn
Mar 31, 2019 40.60 Mn
Mar 31, 2019 40.60 Mn
Dec 31, 2018 37.40 Mn
Dec 31, 2018 37.40 Mn
Sep 30, 2018 38.00 Mn
Sep 30, 2018 38.00 Mn
Jun 30, 2018 36.60 Mn
Jun 30, 2018 36.60 Mn
Mar 31, 2018 36.22 Mn
Mar 31, 2018 36.22 Mn
Dec 31, 2017 33.76 Mn
Dec 31, 2017 33.76 Mn
Sep 30, 2017 34.90 Mn
Sep 30, 2017 34.90 Mn
Jun 30, 2017 33.80 Mn
Jun 30, 2017 33.80 Mn
Mar 31, 2017 30.60 Mn
Mar 31, 2017 30.60 Mn
Dec 31, 2016 27.60 Mn
Dec 31, 2016 27.60 Mn
Sep 30, 2016 26.50 Mn
Sep 30, 2016 26.50 Mn
Jun 30, 2016 21.30 Mn
Jun 30, 2016 21.30 Mn
Mar 31, 2016 20.80 Mn
Mar 31, 2016 20.80 Mn
Dec 31, 2015 17.10 Mn
Dec 31, 2015 17.10 Mn
Sep 30, 2015 17.60 Mn
Sep 30, 2015 17.60 Mn
Jun 30, 2015 17.60 Mn
Jun 30, 2015 17.60 Mn
Mar 31, 2015 17.56 Mn
Mar 31, 2015 17.56 Mn
Dec 31, 2014 15.90 Mn
Dec 31, 2014 15.90 Mn
Sep 30, 2014 15.50 Mn
Sep 30, 2014 15.50 Mn
Jun 30, 2014 15.50 Mn
Jun 30, 2014 15.50 Mn
Mar 31, 2014 15.35 Mn
Mar 31, 2014 15.35 Mn
Dec 31, 2013 9.80 Mn
Dec 31, 2013 9.80 Mn
Sep 30, 2013 9.50 Mn
Sep 30, 2013 9.50 Mn
Jun 30, 2013 9.90 Mn
Jun 30, 2013 9.90 Mn
Mar 31, 2013 9.20 Mn
Mar 31, 2013 9.20 Mn
Dec 31, 2012 9.07 Mn
Dec 31, 2012 9.07 Mn
Sep 30, 2012 9.50 Mn
Sep 30, 2012 9.50 Mn
Jun 30, 2012 9.90 Mn
Jun 30, 2012 9.90 Mn
Mar 31, 2012 9.93 Mn
Mar 31, 2012 9.93 Mn
Dec 31, 2011 7.48 Mn
Dec 31, 2011 7.48 Mn
Sep 30, 2011 7.40 Mn
Sep 30, 2011 7.40 Mn
Jun 30, 2011 7.20 Mn
Jun 30, 2011 7.20 Mn
Mar 31, 2011 6.90 Mn
Mar 31, 2011 6.90 Mn
Dec 31, 2010 4.17 Mn
Dec 31, 2010 4.17 Mn
Sep 30, 2010 4.10 Mn
Sep 30, 2010 4.10 Mn
Jun 30, 2010 3.60 Mn
Jun 30, 2010 3.60 Mn
Mar 31, 2010 3.12 Mn
Mar 31, 2010 3.12 Mn